Adapting to a changing landscape: switching to oncology biosimilars

Adapting to a changing landscape: switching to oncology biosimilars

Emma Foreman, Philippe Arnaud, Glenn Myers
Discussing the primary considerations involved in switching from an originator biologic pharmaceutical product to a biosimilar product.
Watch now
Empowering patients as part of a successful biosimilar switching strategy

Empowering patients as part of a successful biosimilar switching strategy

Emma Foreman, María-José Tamés
Discussing the importance of patient education concerning treatment regimens involving biosimilars with real-world examples.
Watch now
Implementing biosimilars: a case study on pharmacovigilance best practice

Implementing biosimilars: a case study on pharmacovigilance best practice

Glenn Myers, Marta Trojniak
Discussing the added importance of pharmacovigilance during treatment with biosimilars with real-world examples.
Watch now

Other educational activities

Core handbook

Includes chapters on stability, immunogenicity, pharmacovigilance and biosimilars in clinical practice

Learning chapters

Enhance your learnings on the use of biosimilars and test your knowledge with our mini-quizzes

Resource library

A selection of evidence-based and peer-reviewed literature with summaries of key guidance of biosimilar use